Valuation Torrent Pharmaceuticals Limited

Stocks

Delayed Bombay S.E. Other stock markets 01:59:26 18/06/2026 pm IST			5-day change	1st Jan Change
4,436.80 ^INR	-0.26%		-2.85%	+15.56%

25/05	Jefferies Adjusts Torrent Pharmaceuticals' Price Target to INR5,350 From INR4,690, Keeps at Buy	MT
22/05	Torrent Pharmaceuticals Limited, Q4 2026 Earnings Call, May 22, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	4,73,197	5,20,309	8,80,347	10,94,736	14,28,460	15,05,541	-	-
Change	-	9.96%	69.2%	24.35%	30.48%	5.4%	-	-
Enterprise Value (EV) ¹	5,08,027	5,66,719	9,10,767	11,19,846	15,64,790	16,19,009	15,87,582	15,63,693
Change	-	11.55%	60.71%	22.96%	39.73%	3.46%	-1.94%	-1.5%
P/E	60.9x	57.4x	53.1x	57.3x	66x	64.2x	47.3x	39.8x
PBR	7.95x	8.4x	12.8x	14.4x	17x	12.6x	10.3x	9.01x
PEG	-	3.4x	0.6x	3.7x	5x	7.71x	1.3x	2.1x
Capitalization / Revenue	5.56x	5.41x	8.21x	9.51x	10.2x	7.94x	7.07x	6.44x
EV / Revenue	5.97x	5.89x	8.49x	9.72x	11.2x	8.54x	7.46x	6.69x
EV / EBITDA	20.9x	19.9x	27x	30.1x	34.3x	25.9x	21.8x	19.2x
EV / EBIT	28.7x	26.5x	34.4x	38.3x	45.5x	38.7x	30.4x	26.6x
EV / FCF	31.8x	31.6x	32.1x	56.7x	66.7x	43x	31.7x	29.4x
FCF Yield	3.15%	3.17%	3.11%	1.76%	1.5%	2.33%	3.15%	3.41%
Dividend per Share ²	16.5	22	28	32	38	32.26	36.3	43.44
Rate of return	1.18%	1.43%	1.08%	0.99%	0.9%	0.73%	0.82%	0.98%
EPS ²	22.96	26.79	48.94	56.47	63.92	69.24	94.13	111.8
Distribution rate	71.8%	82.1%	57.2%	56.7%	59.4%	46.6%	38.6%	38.8%
Net sales ¹	85,080	96,200	1,07,280	1,15,160	1,39,800	1,89,567	2,12,800	2,33,852
EBITDA ¹	24,310	28,420	33,680	37,210	45,590	62,453	72,984	81,287
EBIT ¹	17,690	21,350	26,480	29,260	34,400	41,862	52,198	58,852
Net income ¹	7,770	12,450	16,560	19,110	21,630	24,749	33,950	41,106
Net Debt ¹	34,830	46,410	30,420	25,110	1,36,330	1,13,469	82,041	58,153
Reference price ²	1,398.15	1,537.35	2,601.15	3,234.60	4,220.65	4,448.40	4,448.40	4,448.40
Nbr of stocks (in thousands)	3,38,445	3,38,445	3,38,445	3,38,445	3,38,445	3,38,445	-	-
Announcement Date	25/05/22	30/05/23	24/05/24	20/05/25	22/05/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
TORRENT PHARMACEUTICALS LIMITED	64.24x	8.54x	25.92x	0.73%	1.6TCr
ELI LILLY AND COMPANY	32.54x	11.83x	24.36x	0.61%	99TCr
JOHNSON & JOHNSON	25.03x	5.77x	15.69x	2.28%	56TCr
ABBVIE INC.	27.45x	6.62x	13.53x	3.1%	39TCr
ROCHE HOLDING AG	17.47x	4.34x	10.68x	3.06%	33TCr
ASTRAZENECA PLC	22.62x	4.72x	13.39x	1.85%	28TCr
NOVARTIS AG	21.12x	5.46x	13.25x	2.94%	28TCr
NOVO NORDISK A/S	12.67x	4.72x	9.72x	3.98%	20TCr
AMGEN INC.	22.21x	5.97x	10.43x	2.95%	18TCr
GILEAD SCIENCES, INC.	-44.95x	5.42x	29.92x	2.59%	16TCr
Average	20.04x	6.34x	16.69x	2.41%	33.87TCr
Weighted average by Cap.	22.35x	7.34x	17.17x	2.12%